The CRO track is skyrocketing

the morning of January 20, the pharmaceutical stocks CRO track all skyrocketed, Tag pharma, Kanglong into a 10% rise, drug Mingkangde rose nearly 7%, Zhao Yan new drugs rose and stopped.Benefiting from the wave of innovative drugs and the global pharmaceutical research and development and production outsourcing industry chain to gather at home, the CRO track in recent years continued its high business climate.A contract research organization is an academic or commercial scientific institution or individual that conducts all or part of a customer's scientific or medical trials in the course of drug development for commercial gain.The CRO industry as an emerging industry, originated in the United States in the 1970s, the early CRO companies in the form of public or private research institutions, small, only for pharmaceutical companies to provide limited drug analysis services. Beginning in the 1980s, as fda regulations in the U.S. continued to improve, the drug development process became more complex, and more and more pharmaceutical companies began to shift some of their work to CRO companies, and the CRO industry entered its innate years.CRO can help pharmaceutical companies reduce research and development costs, reduce research and development risks and improve research and development efficiency, so that the entire pharmaceutical sector to achieve social division of labor specialization, risk averaging.CRO enterprises are divided into preclinical CRO and clinical trial CRO two main categories, the current preclinical CRO is mainly engaged in compound research services and preclinical research services, including compound research services including research, pilot compounds and active drug intermediate synthesis and process development, domestic and foreign companies are mainly Charles River, Covance (has been acquired by LabCorp), Syneos, pharmaceutical Mingkangde (Wuxi Apptec), Zhao yanxin pharmaceutical (Joinn Lab), Kanglong. Preclinical research services include pharmacodynamics, pharmacological toxicology, animal models, etc. Clinical trial CRO mainly focuses on clinical research services, including I to IV clinical trial technical services, clinical trial data management and statistical analysis, registration declaration and post-market drug safety monitoring, domestic and foreign companies are mainly Quintiles IMS (renamed IQVIA, Chinese Kuntai), Covance (acquired by LabCorp), ICON PLC, PAREXEL (Jingding), PRA Health, TigerMed, Boji Pharmaceuticals and so on. (Sina Pharmaceutical News)article: Blue Dot Finance", "Prosperity: Global CRO Industry Analysis and Outlook"